Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis.
about
The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: a single-center study.
P2860
Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Neoadjuvant luteinizing-hormon ...... ensity score-matched analysis.
@en
type
label
Neoadjuvant luteinizing-hormon ...... ensity score-matched analysis.
@en
prefLabel
Neoadjuvant luteinizing-hormon ...... ensity score-matched analysis.
@en
P2093
P2860
P1476
Neoadjuvant luteinizing-hormon ...... ensity score-matched analysis.
@en
P2093
Chikara Ohyama
Koji Mitsuzuka
Norihiko Tsuchiya
Sadafumi Kawamura
Shintaro Narita
Takahiro Yoneyama
Takuya Koie
Tatsuo Tochigi
Tohru Yoneyama
Tomonori Habuchi
P2860
P2888
P304
P356
10.1007/S10147-015-0802-Y
P577
2015-02-15T00:00:00Z
P6179
1033842206